Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
Biochemical Pharmacology|February 4, 2021
Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1Qian Wu, Dan-Qi Chen, Lin Sun, et al.Molecular Cancer Therapeutics|April 2, 2014
MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189Wei Wang, Ying-Qing Wang, Tao Meng, et al.European Journal of Medicinal Chemistry|June 18, 2024
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitorsHongrui Li, Ben-Jin Liu, Jiahao Xu, et al.Marine Drugs|January 19, 2019
Cytotoxic Nitrogenous Terpenoids from Two South China Sea Nudibranchs <i>Phyllidiella pustulosa</i>, <i>Phyllidia coelestis</i>, and Their Sponge-Prey <i>Acanthella cavernosa</i>Qihao Wu, Wen-Ting Chen, Song-Wei Li, et al.Molecular Cancer|October 12, 2010
Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolideZhao-Li Zhou, Zhi-Guo Luo, Bing Yu, et al.Neoplasia (New York, N.Y.)|November 3, 2009
Naphthalimides induce G(2) arrest through the ATM-activated Chk2-executed pathway in HCT116 cellsHong Zhu, Ze-Hong Miao, Min Huang, et al.The Journal of Biological Chemistry|June 11, 2011
Drug transporter-independent liver cancer cell killing by a marine steroid methyl spongoate via apoptosis inductionYi Jiang, Ze-Hong Miao, Lei Xu, et al.Cell Death & Disease|February 16, 2021
Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancerNing Zhang, Yu-Nan Tian, Li-Na Zhou, et al.Journal of Medicinal Chemistry|March 12, 2013
Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8H)-ones bearing a functionalized longer chain appendage as novel PARP1 inhibitorsNa Ye, Chuan-Huizi Chen, Tiantian Chen, et al.Acta Pharmacologica Sinica|April 18, 2017
Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitorsZhong-Min Yang, Xue-Mei Liao, Yi Chen, et al.Pageof 12